Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Aureka lands $100M series B to scale AI drug discovery
1+ hour, 8+ min ago (12+ words) FirstWord Pharma...
Trump orders overhaul of childhood shots, splitting of MMR vaccine
10+ hour, 48+ min ago (12+ words) FirstWord Pharma...
Physician Views Preview: Doctors to weigh Leqembi's new edge as tau enters the fray
9+ hour, 58+ min ago (16+ words) FirstWord Pharma...
BMS to spend $2.3B on 'flexible' manufacturing campus in Texas
11+ hour, 44+ min ago (12+ words) FirstWord Pharma...
AbCellera's hot flash antibody shows promise for once-monthly dosing
12+ hour, 29+ min ago (11+ words) FirstWord Pharma...
FDA rebuffs ITM's radiotherapeutic for neuroendocrine tumours
12+ hour, 29+ min ago (8+ words) firstwordpharma.com...
Silence posts mid-stage polycythemia vera win, preps for Phase III
16+ hour, 34+ min ago (12+ words) FirstWord Pharma...
MoonLake touts Phase III PsA data, but investors may have wanted more
16+ hour, 19+ min ago (14+ words) FirstWord Pharma...
Spotlight On: Takeda breaks new ground with narcolepsy approval as Alkermes and Eli Lilly wait in slipstream
19+ hour, 18+ min ago (19+ words) FirstWord Pharma...
Vertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop
18+ hour, 24+ min ago (14+ words) FirstWord Pharma...